Elevance Health (ELV) Competitors $340.04 -5.82 (-1.68%) Closing price 07/11/2025 03:59 PM EasternExtended Trading$340.00 -0.04 (-0.01%) As of 07/11/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ELV vs. CNC, MOH, UNH, CI, HUM, DHR, CVS, COR, NTRA, and LHShould you be buying Elevance Health stock or one of its competitors? The main competitors of Elevance Health include Centene (CNC), Molina Healthcare (MOH), UnitedHealth Group (UNH), Cigna Group (CI), Humana (HUM), Danaher (DHR), CVS Health (CVS), Cencora (COR), Natera (NTRA), and Labcorp (LH). These companies are all part of the "medical" sector. Elevance Health vs. Its Competitors Centene Molina Healthcare UnitedHealth Group Cigna Group Humana Danaher CVS Health Cencora Natera Labcorp Centene (NYSE:CNC) and Elevance Health (NYSE:ELV) are both large-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, earnings, profitability, media sentiment, valuation and risk. Which has more volatility & risk, CNC or ELV? Centene has a beta of 0.44, indicating that its share price is 56% less volatile than the S&P 500. Comparatively, Elevance Health has a beta of 0.6, indicating that its share price is 40% less volatile than the S&P 500. Do insiders & institutionals have more ownership in CNC or ELV? 93.6% of Centene shares are held by institutional investors. Comparatively, 89.2% of Elevance Health shares are held by institutional investors. 0.4% of Centene shares are held by insiders. Comparatively, 0.3% of Elevance Health shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Do analysts prefer CNC or ELV? Centene presently has a consensus target price of $64.75, indicating a potential upside of 106.08%. Elevance Health has a consensus target price of $495.80, indicating a potential upside of 45.81%. Given Centene's higher probable upside, research analysts plainly believe Centene is more favorable than Elevance Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Centene 0 Sell rating(s) 12 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.33Elevance Health 0 Sell rating(s) 4 Hold rating(s) 12 Buy rating(s) 0 Strong Buy rating(s) 2.75 Is CNC or ELV more profitable? Elevance Health has a net margin of 3.23% compared to Centene's net margin of 2.04%. Elevance Health's return on equity of 18.61% beat Centene's return on equity.Company Net Margins Return on Equity Return on Assets Centene2.04% 14.56% 4.75% Elevance Health 3.23%18.61%6.80% Does the media refer more to CNC or ELV? In the previous week, Elevance Health had 4 more articles in the media than Centene. MarketBeat recorded 69 mentions for Elevance Health and 65 mentions for Centene. Elevance Health's average media sentiment score of 0.69 beat Centene's score of -0.02 indicating that Elevance Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Centene 9 Very Positive mention(s) 4 Positive mention(s) 35 Neutral mention(s) 11 Negative mention(s) 4 Very Negative mention(s) Neutral Elevance Health 34 Very Positive mention(s) 1 Positive mention(s) 27 Neutral mention(s) 3 Negative mention(s) 3 Very Negative mention(s) Positive Which has stronger valuation & earnings, CNC or ELV? Elevance Health has higher revenue and earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Elevance Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCentene$163.07B0.10$3.31B$6.714.68Elevance Health$177.01B0.43$5.98B$25.6313.27 SummaryElevance Health beats Centene on 13 of the 16 factors compared between the two stocks. Get Elevance Health News Delivered to You Automatically Sign up to receive the latest news and ratings for ELV and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ELV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ELV vs. The Competition Export to ExcelMetricElevance HealthMedical Services IndustryMedical SectorNYSE ExchangeMarket Cap$76.97B$7.32B$5.56B$20.65BDividend Yield2.01%2.85%5.06%3.72%P/E Ratio13.2734.5428.2627.84Price / Sales0.4335.94436.6142.29Price / Cash8.6923.1337.1222.32Price / Book1.906.858.044.57Net Income$5.98B$236.02M$3.19B$989.30M7 Day Performance-2.54%0.01%3.62%0.20%1 Month Performance-11.56%2.76%5.98%5.53%1 Year Performance-36.51%33.80%29.39%10.30% Elevance Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ELVElevance Health4.9588 of 5 stars$340.04-1.7%$495.80+45.8%-36.6%$76.97B$177.01B13.27104,200Trending NewsUpcoming EarningsAnalyst ForecastCNCCentene4.9693 of 5 stars$33.04-0.8%$68.87+108.4%-53.7%$16.44B$163.07B4.9260,500Trending NewsAnalyst DowngradeHigh Trading VolumeMOHMolina Healthcare4.9902 of 5 stars$232.60-2.9%$364.21+56.6%-24.7%$12.61B$40.65B11.2318,000Trending NewsAnalyst DowngradeAnalyst RevisionUNHUnitedHealth Group4.9978 of 5 stars$302.80-1.9%$415.57+37.2%-40.6%$274.68B$400.28B12.68400,000Trending NewsUpcoming EarningsAnalyst ForecastCICigna Group4.9985 of 5 stars$312.06-2.4%$380.39+21.9%-9.6%$83.36B$247.12B17.2873,500Positive NewsHUMHumana4.5408 of 5 stars$236.02-1.5%$280.76+19.0%-39.7%$28.49B$117.76B16.6965,680Analyst DowngradeDHRDanaher4.8944 of 5 stars$199.12-2.0%$248.61+24.9%-17.0%$142.50B$23.88B38.6663,000Positive NewsAnalyst ForecastCVSCVS Health4.9955 of 5 stars$66.28-1.7%$75.38+13.7%+9.7%$83.85B$372.81B15.82300,000Trending NewsDividend AnnouncementAnalyst RevisionCORCencora4.5279 of 5 stars$300.58+1.5%$306.33+1.9%+32.6%$58.26B$293.96B34.8746,000Positive NewsNTRANatera1.6524 of 5 stars$159.21-1.6%$184.63+16.0%+43.8%$21.74B$1.70B-108.314,434LHLabcorp4.7122 of 5 stars$257.51-1.7%$276.08+7.2%+20.9%$21.55B$13.01B29.7770,000Trending NewsDividend AnnouncementAnalyst ForecastAnalyst Revision Related Companies and Tools Related Companies Centene Alternatives Molina Healthcare Alternatives UnitedHealth Group Alternatives Cigna Group Alternatives Humana Alternatives Danaher Alternatives CVS Health Alternatives Cencora Alternatives Natera Alternatives Labcorp Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:ELV) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elevance Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Elevance Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ELV Stock Alerts